Dudediligence.

NeoGenomics, Inc

NEONASDAQ · Services-Testing Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$167.8MSep ’24$172.0MDec ’24$168.0MMar ’25$181.3MJun ’25$187.8MSep ’25$190.2MDec ’25$186.7MMar ’26$201.7MJun ’26
Net income, by quarter
−$17.7MSep ’24−$15.3MDec ’24−$25.9MMar ’25−$45.1MJun ’25−$27.1MSep ’25−$9.9MDec ’25−$17.1MMar ’26$2.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$484.3M$509.7M$591.6M$660.6M$727.3M
Gross profit$187.1M$187.9M$244.6M$290.1M$314.3M
Operating income−$118.8M−$157.6M−$107.7M−$92.1M−$115.9M
Net income−$8.3M−$144.3M−$88.0M−$78.7M−$108.0M
Operating cash flow−$26.7M−$66.0M−$2.0M$7.0M$5.2M
Free cash flow−$90.9M−$96.9M−$30.7M−$34.0M−$21.8M
Cash$316.8M$263.2M$342.5M$367.0M$159.6M
Debtnone on filenone on file$538.2M$541.1M$341.9M
Shares outstanding124.1M126.9M127.4M128.1M128.1M